Experts discuss evolving strategies in ER+/HER2– metastatic breast cancer treatment, combining endocrine and targeted therapies, and leveraging specific mutations for optimal patient outcomes. This is ...

Selection of appropriate adjuvant therapy to ultimately reduce the risk of breast cancer (BC) recurrence is a challenge for medical oncologists. Several automated risk prediction models have been ...

Humans differ from other primates due to their relatively large, permanent breasts, and their development has so far not been conclusively explained. According to a study conducted at the University ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the patient will experience a recurrence years after their initial diagnosis. Now, ...

The article by Meisel et al entitled “Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began” (ASCO Educational Book 10.1200/EDBK_201037 ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The breast cancer treatment landscape has ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Before trastuzumab-deruxtecan, we didn't ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Breast cancers can be ...

All mammals have mammary glands that produce milk, a feature that has fascinated scientists for many years. Questions such as why mammary glands evolved in the first place, how they have adapted ...

Breasts are necessary for breastfeeding, but their size is not decisive in terms of milk production. A large part of the breast consists of adipose tissue, and earlier theories have suggested that ...